In the HNSCC, some contradictory reports suggest that a single specimen may adequately represent the PD-L1 expression of the entire tumor, regardless of the degree of intra-tumoral heterogeneity (7), while others indicate that recurrent or metastatic tumors may show distinct PD-L1 expression patterns compared to primary tumors (8). This evidence concerns the gene CD274 and neoplasm.